Abstract
Objectives: To examine differences between demographic and cultural identity group responses on the Society for Clinical Neuropsychology’s (SCN) Strategic Planning Survey. Methods: Respondents were grouped into self-identified demographic and cultural identity groups. Descriptive statistics were used to summarize responses to demographic and survey data. We used Chi-square and Fisher’s Exact tests to compare group differences. Adjusted residuals were calculated for post-hoc testing, when appropriate. Results: Membership satisfaction was high across groups. Respondents who identified as persons of color, women, with a disability, or students/trainees were more likely to indicate that the SCN could better represent them by increasing diversity and inclusion efforts. Persons of color and other historically marginalized/minoritized groups viewed the SCN’s equity, diversity, and inclusion (EDI) efforts as less successful than comparative groups, but they expressed more optimism that initiatives could increase the engagement of persons of color in the SCN. Respondents earlier in their career and from marginalized/minoritized groups more frequently viewed the lack of diversity in clinical neuropsychology as an important issue facing the specialty and the desire for the SCN to prioritize improving EDI within clinical neuropsychology. Women and earlier career respondents were more likely to indicate that the SCN should focus efforts on increasing clinical neuropsychology’s value to society. Conclusions: Respondents earlier in their careers and from marginalized/minoritized groups were more likely to identify EDI related issues as significant to the SCN and specialty, and a desire for the SCN to prioritize efforts to improve EDI.
| Original language | English |
|---|---|
| Journal | Clinical Neuropsychologist |
| DOIs | |
| State | Accepted/In press - 2025 |
Bibliographical note
Publisher Copyright:© 2025 Informa UK Limited, trading as Taylor & Francis Group.
Funding
Dr. Shawn M. McClintock reports research support from the National Institutes of Health. He is a consultant to Pearson, receives teaching honoraria from Duke University School of Medicine, and receives royalties from Guilford Press, Inc. Dr. Sara L. Weisenbach reports research support from the National Institutes of Health. She serves on advisory panels for QBTech and Otsuka Pharmaceuticals. Drs. Scott A. Sperling, Lynette Abrams-Silva, Franchesca Arias, Samantha DeDios-Stern, Amy J. Jak, Justin E. Karr, Tricia Z. King, Cynthia S. Kubu, Margaret Lanca, David Lechuga, Michelle R. Madore, Emily C. Murriel, Becky Ready, Zachary J. Resch, Paula Shear, and Anthony Y. Stringer declare no competing interests.
| Funders |
|---|
| National Institutes of Health (NIH) |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Society for Clinical Neuropsychology
- advocacy
- clinical neuropsychology
- diversity equity justice and inclusion
- strategic planning
ASJC Scopus subject areas
- Neuropsychology and Physiological Psychology
- Developmental and Educational Psychology
- Clinical Psychology
- Arts and Humanities (miscellaneous)
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'The Society for Clinical Neuropsychology’s 2023 strategic plan: Group differences in strategic planning survey results'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver